166 related articles for article (PubMed ID: 25216338)
21. Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo.
Wang J; Li Y; Wang L; Wang X; Tu P
Drug Deliv; 2018 Nov; 25(1):330-340. PubMed ID: 29350064
[TBL] [Abstract][Full Text] [Related]
22. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.
Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J
Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759
[TBL] [Abstract][Full Text] [Related]
23. Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery.
Park JH; Lee JY; Termsarasab U; Yoon IS; Ko SH; Shim JS; Cho HJ; Kim DD
Int J Pharm; 2014 Oct; 473(1-2):426-33. PubMed ID: 25079433
[TBL] [Abstract][Full Text] [Related]
24. Novel polymeric micelles based on the amphiphilic diblock copolymer poly(N-vinyl-2-pyrrolidone)-block-poly(D,L-lactide).
Benahmed A; Ranger M; Leroux JC
Pharm Res; 2001 Mar; 18(3):323-8. PubMed ID: 11442272
[TBL] [Abstract][Full Text] [Related]
25. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
[TBL] [Abstract][Full Text] [Related]
26. Improved therapeutic effect of DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab')(2) for hepatocellular carcinoma.
Jin C; Qian N; Zhao W; Yang W; Bai L; Wu H; Wang M; Song W; Dou K
Biomacromolecules; 2010 Sep; 11(9):2422-31. PubMed ID: 20831277
[TBL] [Abstract][Full Text] [Related]
27. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles.
Lin R; Shi Ng L; Wang CH
Biomaterials; 2005 Jul; 26(21):4476-85. PubMed ID: 15701377
[TBL] [Abstract][Full Text] [Related]
28. Polysaccharide-modified nanoparticles with intelligent CD44 receptor targeting ability for gene delivery.
Lin WJ; Lee WC
Int J Nanomedicine; 2018; 13():3989-4002. PubMed ID: 30022822
[TBL] [Abstract][Full Text] [Related]
29. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells.
Wang H; Agarwal P; Zhao S; Xu RX; Yu J; Lu X; He X
Biomaterials; 2015 Dec; 72():74-89. PubMed ID: 26344365
[TBL] [Abstract][Full Text] [Related]
30. Doxorubicin release from core-shell type nanoparticles of poly(DL-lactide-co-glycolide)-grafted dextran.
Jeong YI; Choi KC; Song CE
Arch Pharm Res; 2006 Aug; 29(8):712-9. PubMed ID: 16964768
[TBL] [Abstract][Full Text] [Related]
31. Targeted and controlled drug delivery system loading artersunate for effective chemotherapy on CD44 overexpressing cancer cells.
Tran TH; Nguyen TD; Van Nguyen H; Nguyen HT; Kim JO; Yong CS; Nguyen CN
Arch Pharm Res; 2016 May; 39(5):687-94. PubMed ID: 27015824
[TBL] [Abstract][Full Text] [Related]
32. CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel.
Muntimadugu E; Kumar R; Saladi S; Rafeeqi TA; Khan W
Colloids Surf B Biointerfaces; 2016 Jul; 143():532-546. PubMed ID: 27045981
[TBL] [Abstract][Full Text] [Related]
33. Self-assembled micelles based on Chondroitin sulfate/poly (d,l-lactideco-glycolide) block copolymers for doxorubicin delivery.
Zhang H; Xu J; Xing L; Ji J; Yu A; Zhai G
J Colloid Interface Sci; 2017 Apr; 492():101-111. PubMed ID: 28073063
[TBL] [Abstract][Full Text] [Related]
34. Reduction sensitive hyaluronan-SS-poly(ε-caprolactone) block copolymers as theranostic nanocarriers for tumor diagnosis and treatment.
Yang H; Wang N; Mo L; Wu M; Yang R; Xu X; Huang Y; Lin J; Zhang LM; Jiang X
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():9-18. PubMed ID: 30813097
[TBL] [Abstract][Full Text] [Related]
35. BCNU-loaded poly(D, L-lactide-co-glycolide) wafer and antitumor activity against XF-498 human CNS tumor cells in vitro.
Seong H; An TK; Khang G; Choi SU; Lee CO; Lee HB
Int J Pharm; 2003 Jan; 251(1-2):1-12. PubMed ID: 12527170
[TBL] [Abstract][Full Text] [Related]
36. Polymeric micelle for tumor pH and folate-mediated targeting.
Lee ES; Na K; Bae YH
J Control Release; 2003 Aug; 91(1-2):103-13. PubMed ID: 12932642
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxic enhancement of hexapeptide-conjugated micelles in EGFR high-expressed cancer cells.
Lin WJ; Kao LT
Expert Opin Drug Deliv; 2014 Oct; 11(10):1537-50. PubMed ID: 24950257
[TBL] [Abstract][Full Text] [Related]
38. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
[TBL] [Abstract][Full Text] [Related]
39. Ultrasound-triggered drug release and enhanced anticancer effect of doxorubicin-loaded poly(D,L-lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanodroplets.
Du L; Jin Y; Zhou W; Zhao J
Ultrasound Med Biol; 2011 Aug; 37(8):1252-8. PubMed ID: 21683513
[TBL] [Abstract][Full Text] [Related]
40. Thermally sensitive micelles self-assembled from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) for controlled delivery of paclitaxel.
Liu SQ; Tong YW; Yang YY
Mol Biosyst; 2005 Jul; 1(2):158-65. PubMed ID: 16880979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]